Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on 89bio (ETNB – Research Report) today and set a price target of $29.00. The ...

Cantor Fitzgerald lowered their FY2024 EPS estimates for shares of CVS Health in a report issued on Tuesday, December 31st.

CJ Muse, Cantor Fitzgerald analyst, joins 'Squawk on the Street' to discuss the latest news regarding Qualcomm, if it's still ...

https://www.tipranks.com/news/the-fly/cantor-fitzgerald-bullish-on-avita-medical-after-fda-approval-for-recell-go-mini Cantor Fitzgerald reiterates an Overweight ...

Cantor Fitzgerald Equity Opportunity Fd earns a Low Process Pillar rating. The primary detractor from the rating is the fund's unimpressive long-term risk-adjusted performance. This can be seen in ...

The Securities and Exchange Commission (SEC) on Thursday charged Cantor Fitzgerald L.P., a global financial services firm headed by one ...

Global Petroleum PLC has announced a change in its voting rights structure, with Cantor Fitzgerald Europe acquiring a significant stake. This acquisition raises Cantor Fitzgerald’s voting rights ...

Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat smaller ...

Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) has been given a consensus rating of “Buy” by the six ratings firms that are covering the firm, MarketBeat Ratings reports. Six research analysts ...

Brandon, 26, has been with Cantor Fitzgerald, L.P., involved in managing strategy and overseeing special projects. His previous roles included equities trader at Cantor Fitzgerald & Co. and credit ...

Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat ...

Tether has made a $775 million investment in Rumble, a video-sharing platform known for championing free speech.